Novartis Ag-sponsored Adr (NVS) SEC 13F Holdings (Q2 2026): Institutional Buyers & Sellers

NVS ranks #212 out of 37501 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

1641 institutions disclose a position in NVS, but none treat it as a major bet — even Cullen Capital Management, LLC, its most concentrated holder, allocates just 3.1% of its own portfolio to it.

Fisher Asset Management, LLC has added to its NVS position for two straight quarters, increasing it by $1.4B to reach $2.4B today.

Dodge & Cox has trimmed its NVS position for two straight quarters, cutting it by $1.1B while still holding $119.0M.

NVS is up 0.8% today, but institutions show net selling of $909.0M this quarter — a divergence between today's price move and the underlying institutional flow.

NVS closed its latest fiscal year with net income of $14.0B.

• Profitable — net income of $14.0B in the latest fiscal year
• Net income improved year over year, from $11.9B to $14.0B
• Generated $19.1B in positive operating cash flow
• Current ratio of 1.12x — below the conventional 1.5x liquidity buffer
• Liabilities run 1.38x equity — within a conventional range